数据链接：
官方服务：
资源简介：
Thrombin Inhibition by Pyridin Derivatives
应用场景：
创建时间：
2024-10-16
相关数据集
HTS Cluster 1 and Singleton hits.
1As of 09/03/09. Number of bioassays in which the compound was tested/number in which the compound was active/number in which the compound has been confirmed as an inhibitor.
NIAID Data Ecosystem40
Lead Optimization of Butyrolactone I as an Orally Bioavailable Antiallergic Agent Targeting FcγRIIB
Food allergy (FA) poses a growing global food safety concern, yet no effective cure exists in clinics. Previously, we discovered a potent antifood allergy compound, butyrolactone I (BTL-I, 1), from th
Figshare2024-04-19 更新20
Predicted physicochemical properties related to drug-likeness of lead compounds.
Predicted physicochemical properties related to drug-likeness of lead compounds.
Figshare2025-09-11 更新20
ADMET Properties, Docking Scores, and MD Simulation Metrics of Lead Compounds.
ADMET Properties, Docking Scores, and MD Simulation Metrics of Lead Compounds.
Figshare2025-06-09 更新30
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
The antiplasmodial activity, DMPK properties, and efficacy of a series of quinoline-4-carboxamides are described. This series was identified from a phenotypic screen against the blood stage of Plasmod
Figshare2016-09-01 更新20
